AI-generated summary
This randomized, placebo-controlled trial compared extraoral and intraoral low-level laser therapy with a placebo after removal of lower third molars in 48 patients. The authors report that extraoral laser therapy was associated with less trismus and facial swelling on the second postoperative day than placebo, and less trismus on the seventh day, while intraoral therapy reduced trismus only on the seventh day.
- Participants
- 48
- Who or what was studied
- Patients scheduled for surgical removal of mandibular (lower) third molars, randomly allocated to extraoral LLLT, intraoral LLLT, or placebo (16 per group).
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes a relatively small sample of 16 patients per group and does not report any longer-term follow-up beyond the seventh postoperative day.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power
- 100 mW, 0.1 W
- Total energy
- 12 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.